Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis

ObjectivesPsoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms remain incompletely understood. As cytokines are key elements to induce and tune up immune responses to drive inflammatory diseases, our objecti...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 993363
Main Authors Larid, Guillaume, Delwail, Adriana, Dalle, Thomas, Vasseur, Philippe, Silvain, Christine, Jégou, Jean-François, Morel, Franck, Lecron, Jean-Claude, Gervais, Elisabeth
Format Journal Article
LanguageEnglish
Published Frontiers 08.11.2022
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ObjectivesPsoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms remain incompletely understood. As cytokines are key elements to induce and tune up immune responses to drive inflammatory diseases, our objective was to assess whether clinical features, disease phenotype and PsA and PsO activity were associated with a particular ex vivo cytokine production profile. MethodsForty-eight patients (37 PsA and 11 PsO) and 11 healthy subjects (HS) were studied. Cytokine production by peripheral blood mononuclear cells (PBMC) that were either unstimulated, or stimulated with LPS or anti-CD3/CD28 antibodies, were analysed by multiplex assay in the culture supernatants. ResultsCytokine signature of PsD includes a high level of TNFα in supernatants of LPS-stimulated PBMC, higher levels of IL-6 and lower levels of IFN-γ and IL-17A after CD3-CD28 stimulation, as well as higher spontaneous IL-1RA and TNFα production compared to HS. High body mass index (BMI) was associated with lower levels of IL-1β, and metabolic syndrome with lower levels of IFN-γ after LPS stimulation. In PsD, dermatological activity was related with higher IL-17A level, while rheumatic activity was linked with lower levels of IFN-γ and TNFα. Comparing each PsD subtype to HS, IL-1β and IL-6 productions are higher when using LPS stimulation in PsO patients with higher levels of IL-1β and IL-1α in peripheral PsA patients after CD3/CD28 stimulation. LPS stimulation induced high levels of IL-17A in peripheral PsA compared to axial PsA. PsA patients with axial PsA share some features with PsO but shows a distinct cytokine pattern compared to peripheral PsA. ConclusionPsO and the different PsA subtypes exhibit distinct ex vivo cytokine production profiles and common features of the so-called PsD. Analysis of IL-1 cytokine family and IL-6 seems to be of particular interest to distinguish PsO and peripheral PsA since it depends on monocytes in PsO and T-lymphocytes in peripheral PsA. Peripheral cytokine profiles are influenced by rheumatic and dermatological activity of the disease, and also by metabolic syndrome features. Our results highlight the crucial role of immune cell interactions with different patterns of interaction depending on clinical phenotype.
AbstractList ObjectivesPsoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms remain incompletely understood. As cytokines are key elements to induce and tune up immune responses to drive inflammatory diseases, our objective was to assess whether clinical features, disease phenotype and PsA and PsO activity were associated with a particular ex vivo cytokine production profile. MethodsForty-eight patients (37 PsA and 11 PsO) and 11 healthy subjects (HS) were studied. Cytokine production by peripheral blood mononuclear cells (PBMC) that were either unstimulated, or stimulated with LPS or anti-CD3/CD28 antibodies, were analysed by multiplex assay in the culture supernatants. ResultsCytokine signature of PsD includes a high level of TNFα in supernatants of LPS-stimulated PBMC, higher levels of IL-6 and lower levels of IFN-γ and IL-17A after CD3-CD28 stimulation, as well as higher spontaneous IL-1RA and TNFα production compared to HS. High body mass index (BMI) was associated with lower levels of IL-1β, and metabolic syndrome with lower levels of IFN-γ after LPS stimulation. In PsD, dermatological activity was related with higher IL-17A level, while rheumatic activity was linked with lower levels of IFN-γ and TNFα. Comparing each PsD subtype to HS, IL-1β and IL-6 productions are higher when using LPS stimulation in PsO patients with higher levels of IL-1β and IL-1α in peripheral PsA patients after CD3/CD28 stimulation. LPS stimulation induced high levels of IL-17A in peripheral PsA compared to axial PsA. PsA patients with axial PsA share some features with PsO but shows a distinct cytokine pattern compared to peripheral PsA. ConclusionPsO and the different PsA subtypes exhibit distinct ex vivo cytokine production profiles and common features of the so-called PsD. Analysis of IL-1 cytokine family and IL-6 seems to be of particular interest to distinguish PsO and peripheral PsA since it depends on monocytes in PsO and T-lymphocytes in peripheral PsA. Peripheral cytokine profiles are influenced by rheumatic and dermatological activity of the disease, and also by metabolic syndrome features. Our results highlight the crucial role of immune cell interactions with different patterns of interaction depending on clinical phenotype.
Objectives Psoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms remain incompletely understood. As cytokines are key elements to induce and tune up immune responses to drive inflammatory diseases, our objective was to assess whether clinical features, disease phenotype and PsA and PsO activity were associated with a particular ex vivo cytokine production profile. Methods Forty-eight patients (37 PsA and 11 PsO) and 11 healthy subjects (HS) were studied. Cytokine production by peripheral blood mononuclear cells (PBMC) that were either unstimulated, or stimulated with LPS or anti-CD3/CD28 antibodies, were analysed by multiplex assay in the culture supernatants. Results Cytokine signature of PsD includes a high level of TNFα in supernatants of LPS-stimulated PBMC, higher levels of IL-6 and lower levels of IFN-γ and IL-17A after CD3-CD28 stimulation, as well as higher spontaneous IL-1RA and TNFα production compared to HS. High body mass index (BMI) was associated with lower levels of IL-1β, and metabolic syndrome with lower levels of IFN-γ after LPS stimulation. In PsD, dermatological activity was related with higher IL-17A level, while rheumatic activity was linked with lower levels of IFN-γ and TNFα. Comparing each PsD subtype to HS, IL-1β and IL-6 productions are higher when using LPS stimulation in PsO patients with higher levels of IL-1β and IL-1α in peripheral PsA patients after CD3/CD28 stimulation. LPS stimulation induced high levels of IL-17A in peripheral PsA compared to axial PsA. PsA patients with axial PsA share some features with PsO but shows a distinct cytokine pattern compared to peripheral PsA. Conclusion PsO and the different PsA subtypes exhibit distinct ex vivo cytokine production profiles and common features of the so-called PsD. Analysis of IL-1 cytokine family and IL-6 seems to be of particular interest to distinguish PsO and peripheral PsA since it depends on monocytes in PsO and T-lymphocytes in peripheral PsA. Peripheral cytokine profiles are influenced by rheumatic and dermatological activity of the disease, and also by metabolic syndrome features. Our results highlight the crucial role of immune cell interactions with different patterns of interaction depending on clinical phenotype.
Author Dalle, Thomas
Delwail, Adriana
Silvain, Christine
Vasseur, Philippe
Jégou, Jean-François
Larid, Guillaume
Lecron, Jean-Claude
Morel, Franck
Gervais, Elisabeth
AuthorAffiliation 1 Rheumatology Department, CHU de Poitiers , Poitiers , France
2 University of Poitiers, LITEC , Poitiers , France
5 Immunology-Inflammation Laboratory, CHU de Poitiers , Poitiers , France
3 UMR 6041, 4CS, Université de Poitiers , Poitiers , France
4 Gastroenterology Department, CHU de Poitiers , Poitiers , France
AuthorAffiliation_xml – name: 2 University of Poitiers, LITEC , Poitiers , France
– name: 3 UMR 6041, 4CS, Université de Poitiers , Poitiers , France
– name: 1 Rheumatology Department, CHU de Poitiers , Poitiers , France
– name: 5 Immunology-Inflammation Laboratory, CHU de Poitiers , Poitiers , France
– name: 4 Gastroenterology Department, CHU de Poitiers , Poitiers , France
Author_xml – sequence: 1
  givenname: Guillaume
  surname: Larid
  fullname: Larid, Guillaume
– sequence: 2
  givenname: Adriana
  surname: Delwail
  fullname: Delwail, Adriana
– sequence: 3
  givenname: Thomas
  surname: Dalle
  fullname: Dalle, Thomas
– sequence: 4
  givenname: Philippe
  surname: Vasseur
  fullname: Vasseur, Philippe
– sequence: 5
  givenname: Christine
  surname: Silvain
  fullname: Silvain, Christine
– sequence: 6
  givenname: Jean-François
  surname: Jégou
  fullname: Jégou, Jean-François
– sequence: 7
  givenname: Franck
  surname: Morel
  fullname: Morel, Franck
– sequence: 8
  givenname: Jean-Claude
  surname: Lecron
  fullname: Lecron, Jean-Claude
– sequence: 9
  givenname: Elisabeth
  surname: Gervais
  fullname: Gervais, Elisabeth
BackLink https://univ-poitiers.hal.science/hal-03894861$$DView record in HAL
BookMark eNpdks9u3CAQxlGVqkm3eYDeOLaH3fLPYPdQKYqSJtJKvaRnxMKwS-o1Ltib5gn62sHxqkrKAdDMfD8G-N6jky52gNBHSlac180XH_b7ccUIY6um4VzyN-iMSimWnDFx8mJ_is5zvidliFLHq3folEvBJFfkDP29-oMP4RCxfRzir9AB7lN0ox1C7HDocJ9jCmYIFruQwWT4iu_ig0ku49yDDb5kcth2ZhgT5Elhx8F0EMd81OaQsekc7iGFfgfJtC-gJg27FIaQP6C33rQZzo_rAv28vrq7vFmuf3y_vbxYL61QclgCZ0IY6zxlwMpc8YpYwSvpoGmYqKEynoGX1FWiYowLooTbCCKYVw2zlC_Q7cx10dzrPoW9SY86mqCfAzFtdekp2Ba0NZ4qKU29oZXwnNWNtOCV9I3aUEdcYX2bWf242YOz0A3ldq-grzNd2OltPOhGqrop3S3Q5xmw-092c7HWU4yUjxa1pIep8U_Hw1L8PUIe9D5kC207P7ZmSpCKMqpUKaVzqU0x5wT-H5sSPXlHP3tHT97Rs3f4E0B5u_Y
CitedBy_id crossref_primary_10_3390_jcm12083046
Cites_doi 10.1038/s41586-021-03188-w
10.1016/j.jaad.2015.05.001
10.3389/fimmu.2014.00316
10.1002/art.27622
10.1172/jci.insight.139793
10.1111/j.1365-2230.2009.03704.x
10.1038/s41598-019-41655-7
10.1161/CIRCULATIONAHA.105.169404
10.1038/ni1254
10.1007/s002960050111
10.1016/S0140-6736(14)61909-7
10.1371/journal.pone.0252116
10.1016/S0923-1811(99)00031-6
10.5114/ada.2018.77665
10.1007/s11926-008-0050-5
10.1016/S0022-1759(03)00010-3
10.1002/eji.1830270125
10.1002/acr.20017
10.1186/s40169-019-0236-7
10.26355/eurrev_201711_13834
10.1038/ncprheum0670
10.1016/S0923-1811(96)00562-2
10.1155/2020/8065147
10.1016/j.autrev.2016.09.015
10.1155/2014/528105
10.1073/pnas.0808144106
10.1016/S1074-7613(00)00078-9
10.1038/ni1497
10.1016/S0140-6736(18)30830-4
10.1186/ar4317
10.1093/rheumatology/keaa405
10.1111/1346-8138.12560
10.1080/08830185.2016.1269175
10.1159/000331390
10.1177/039463200802100318
10.1111/ced.12251
10.1016/j.it.2008.07.002
10.1093/rheumatology/key069
10.1093/rheumatology/kel306
10.1097/MCO.0b013e32833cf3bc
10.1136/ard.2004.031237
10.1155/2020/7420823
10.1002/art.21972
10.1016/j.jid.2018.07.025
10.1182/blood.V75.6.1305.1305
10.1016/j.ejmhg.2017.09.002
10.3945/an.115.010207
10.1007/s10067-014-2807-8
10.1007/s12016-018-8702-3
10.1111/j.1365-2133.2005.06648.x
10.3390/ijms19030774
10.3389/fimmu.2021.636720
10.3899/jrheum.190054
10.1007/s11926-017-0692-2
10.1136/ard.2004.032482
10.1111/1523-1747.ep12477880
10.1186/s12881-018-0742-2
10.4049/jimmunol.179.1.41
10.1111/j.1365-2133.2010.09992.x
10.1111/j.1529-8019.2010.01303.x
10.1093/rap/rkaa033
10.1093/rheumatology/kez457
10.3390/molecules25184322
10.1177/2058738420907186
ContentType Journal Article
Copyright Attribution
Copyright © 2022 Larid, Delwail, Dalle, Vasseur, Silvain, Jégou, Morel, Lecron and Gervais 2022 Larid, Delwail, Dalle, Vasseur, Silvain, Jégou, Morel, Lecron and Gervais
Copyright_xml – notice: Attribution
– notice: Copyright © 2022 Larid, Delwail, Dalle, Vasseur, Silvain, Jégou, Morel, Lecron and Gervais 2022 Larid, Delwail, Dalle, Vasseur, Silvain, Jégou, Morel, Lecron and Gervais
DBID AAYXX
CITATION
7X8
1XC
VOOES
5PM
DOA
DOI 10.3389/fimmu.2022.993363
DatabaseName CrossRef
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
EndPage 993363
ExternalDocumentID oai_doaj_org_article_caf1766a8b154f32896cef76f97b1d0d
oai_HAL_hal_03894861v1
10_3389_fimmu_2022_993363
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c476t-e3244acdf12e2df15350c4356de99248e5af2ef61d5452234074db4042f792c13
IEDL.DBID RPM
ISSN 1664-3224
IngestDate Tue Oct 22 15:09:31 EDT 2024
Tue Sep 17 21:34:44 EDT 2024
Fri Nov 15 06:55:18 EST 2024
Sat Oct 05 04:21:11 EDT 2024
Thu Nov 21 21:22:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License Attribution: http://creativecommons.org/licenses/by
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-e3244acdf12e2df15350c4356de99248e5af2ef61d5452234074db4042f792c13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Rajeev Kumar Pandey, Johns Hopkins Medicine, United States; Olesya Plazyo, Michigan Medicine, University of Michigan, United States
ORCID: Elisabeth Gervais, 0000-0003-3513-2989
This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
Edited by: Mrinal K. Sarkar, University of Michigan, United States
ORCID 0000-0002-5818-6042
0000-0002-0712-8491
0000-0003-3812-9304
0000-0003-3990-5213
0000-0002-9703-5976
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678922/
PMID 36426370
PQID 2740512177
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_caf1766a8b154f32896cef76f97b1d0d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9678922
hal_primary_oai_HAL_hal_03894861v1
proquest_miscellaneous_2740512177
crossref_primary_10_3389_fimmu_2022_993363
PublicationCentury 2000
PublicationDate 2022-11-08
PublicationDateYYYYMMDD 2022-11-08
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-08
  day: 08
PublicationDecade 2020
PublicationTitle Frontiers in immunology
PublicationYear 2022
Publisher Frontiers
Frontiers Media S.A
Publisher_xml – name: Frontiers
– name: Frontiers Media S.A
References Ritchlin (B3) 2007; 3
Lubrano (B4) 2019; 46
Salaffi (B20) 2014; 2014
Wani (B7) 2018; 19
Coimbra (B14) 2010; 163
Aguilar-Flores (B59) 2020; 2020
Poubelle (B44) 2019; 8
Nishibu (B16) 1999; 21
Danis (B30) 2018; 19
Scarpa (B2) 2006; 33
Zhou (B25) 2010; 13
Trickett (B23) 2003; 275
Gladman (B27) 2005; 64
Andersen (B39) 2016; 7
Vaure (B33) 2014; 5
Bautista-Herrera (B11) 2020; 34
Blauvelt (B48) 2018; 55
Grundy (B22) 2005; 112
Amos (B32) 2012; 195
Pirowska (B13) 2018; 35
Benham (B36) 2013; 15
Yamanaka (B45) 2014; 41
Michalak-Stoma (B60) 2020; 2020
Boehncke (B26) 2015; 386
Ganesan (B29) 2017; 36
Feldman (B19) 2005; 64
Evans (B53) 2009; 106
Cordiali-Fei (B64) 2008; 21
Cuchacovich (B66) 2014; 33
Rech (B1) 2020; 4
Villani (B6) 2015; 73
Harrington (B62) 2005; 6
Feld (B54) 2020; 59
Bosè (B17) 2014; 39
Wilson (B49) 2007; 8
Veale (B28) 2018; 391
Fernández-Sueiro (B21) 2010; 62
Ramírez-Pérez (B24) 2020; 25
Sakkas (B63) 2017; 16
Duffin (B9) 2010; 23
Leijten (B38) 2021; 60
Neuner (B43) 1991; 97
Bielecki (B51) 2021; 592
Colombo (B58) 2017; 21
Zanin-Zhorov (B34) 2007; 179
Tosato (B46) 1990; 75
Wang (B42) 2019; 9
Kelchtermans (B61) 2008; 29
Diehl (B41) 2000; 13
Leipe (B37) 2010; 62
Takahashi (B15) 2009; 35
Szodoray (B10) 2007; 46
Mizutani (B57) 1997; 14
Sobchak (B5) 2017; 19
Chizzolini (B52) 1997; 27
Elkayam (B12) 2000; 19
Lawlor (B35) 2021; 12
Traks (B8) 2019; 20
Mastroianni (B65) 2005; 153
Taylor (B18) 2006; 54
Porsche (B40) 2021; 6
Madureira (B47) 2016; 41
Mensah (B31) 2008; 10
Kato (B55) 2021; 16
Cai (B50) 2019; 139
Miyagawa (B56) 2019; 58
References_xml – volume: 592
  year: 2021
  ident: B51
  article-title: Skin-resident innate lymphoid cells converge on a pathogenic effector state
  publication-title: Nature
  doi: 10.1038/s41586-021-03188-w
  contributor:
    fullname: Bielecki
– volume: 41
  year: 2016
  ident: B47
  article-title: Off-label use of tocilizumab in psoriatic arthritis: Case series and review of the literature
  publication-title: Acta Reumatol Port
  contributor:
    fullname: Madureira
– volume: 73
  year: 2015
  ident: B6
  article-title: Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2015.05.001
  contributor:
    fullname: Villani
– volume: 5
  year: 2014
  ident: B33
  article-title: A comparative review of toll-like receptor 4 expression and functionality in different animal species
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00316
  contributor:
    fullname: Vaure
– volume: 62
  year: 2010
  ident: B37
  article-title: Role of Th17 cells in human autoimmune arthritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27622
  contributor:
    fullname: Leipe
– volume: 6
  year: 2021
  ident: B40
  article-title: Obesity results in adipose tissue T cell exhaustion
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.139793
  contributor:
    fullname: Porsche
– volume: 35
  year: 2009
  ident: B15
  article-title: Serum cytokines and growth factor levels in Japanese patients with psoriasis: Serum cytokine levels and disease activity of psoriasis
  publication-title: Clin Exp Dermatol
  doi: 10.1111/j.1365-2230.2009.03704.x
  contributor:
    fullname: Takahashi
– volume: 9
  start-page: 5310
  year: 2019
  ident: B42
  article-title: Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-41655-7
  contributor:
    fullname: Wang
– volume: 112
  year: 2005
  ident: B22
  article-title: Diagnosis and management of the metabolic syndrome: An American heart Association/National heart, lung, and blood institute scientific statement
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
  contributor:
    fullname: Grundy
– volume: 6
  year: 2005
  ident: B62
  article-title: Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
  publication-title: Nat Immunol
  doi: 10.1038/ni1254
  contributor:
    fullname: Harrington
– volume: 19
  year: 2000
  ident: B12
  article-title: Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis
  publication-title: Rheumatol Int
  doi: 10.1007/s002960050111
  contributor:
    fullname: Elkayam
– volume: 386
  year: 2015
  ident: B26
  article-title: Psoriasis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61909-7
  contributor:
    fullname: Boehncke
– volume: 16
  year: 2021
  ident: B55
  article-title: Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis
  publication-title: PloS One
  doi: 10.1371/journal.pone.0252116
  contributor:
    fullname: Kato
– volume: 21
  start-page: 63
  year: 1999
  ident: B16
  article-title: Overexpression of monocyte-derived cytokines in active psoriasis: A relation to coexistent arthropathy
  publication-title: J Dermatol Sci
  doi: 10.1016/S0923-1811(99)00031-6
  contributor:
    fullname: Nishibu
– volume: 35
  year: 2018
  ident: B13
  article-title: The level of proinflammatory cytokines: Interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis
  publication-title: Adv Dermatol Allergol
  doi: 10.5114/ada.2018.77665
  contributor:
    fullname: Pirowska
– volume: 10
  year: 2008
  ident: B31
  article-title: Altered bone remodeling in psoriatic arthritis
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-008-0050-5
  contributor:
    fullname: Mensah
– volume: 275
  year: 2003
  ident: B23
  article-title: T Cell stimulation and expansion using anti-CD3/CD28 beads
  publication-title: J Immunol Methods
  doi: 10.1016/S0022-1759(03)00010-3
  contributor:
    fullname: Trickett
– volume: 27
  year: 1997
  ident: B52
  article-title: Human Th1 cells preferentially induce interleukin (IL)-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830270125
  contributor:
    fullname: Chizzolini
– volume: 62
  start-page: 78
  year: 2010
  ident: B21
  article-title: Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.20017
  contributor:
    fullname: Fernández-Sueiro
– volume: 8
  start-page: 19
  year: 2019
  ident: B44
  article-title: The use of leukocytes’ secretome to individually target biological therapy in autoimmune arthritis: A case report
  publication-title: Clin Trans Med
  doi: 10.1186/s40169-019-0236-7
  contributor:
    fullname: Poubelle
– volume: 21
  year: 2017
  ident: B58
  article-title: Peripheral blood CD8+ T-cell profiles in patients with psoriatic arthritis: A cross-sectional case-control study
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201711_13834
  contributor:
    fullname: Colombo
– volume: 3
  start-page: 698
  year: 2007
  ident: B3
  article-title: Psoriatic disease–from skin to bone
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/ncprheum0670
  contributor:
    fullname: Ritchlin
– volume: 14
  year: 1997
  ident: B57
  article-title: Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis: Relation to focal infection, disease activity and responses to treatments
  publication-title: J Dermatol Sci
  doi: 10.1016/S0923-1811(96)00562-2
  contributor:
    fullname: Mizutani
– volume: 2020
  start-page: 1
  year: 2020
  ident: B59
  article-title: Association of pathogenic Th17 cells with the disease severity and its potential implication for biological treatment selection in psoriasis patients
  publication-title: Mediators Inflammation
  doi: 10.1155/2020/8065147
  contributor:
    fullname: Aguilar-Flores
– volume: 16
  year: 2017
  ident: B63
  article-title: Are psoriasis and psoriatic arthritis the same disease? the IL-23/IL-17 axis data
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2016.09.015
  contributor:
    fullname: Sakkas
– volume: 2014
  start-page: 1
  year: 2014
  ident: B20
  article-title: Disease activity in psoriatic arthritis: Comparison of the discriminative capacity and construct validity of six composite indices in a real world
  publication-title: BioMed Res Int
  doi: 10.1155/2014/528105
  contributor:
    fullname: Salaffi
– volume: 106
  year: 2009
  ident: B53
  article-title: In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0808144106
  contributor:
    fullname: Evans
– volume: 13
  year: 2000
  ident: B41
  article-title: Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)00078-9
  contributor:
    fullname: Diehl
– volume: 8
  year: 2007
  ident: B49
  article-title: Development, cytokine profile and function of human interleukin 17–producing helper T cells
  publication-title: Nat Immunol
  doi: 10.1038/ni1497
  contributor:
    fullname: Wilson
– volume: 391
  year: 2018
  ident: B28
  article-title: The pathogenesis of psoriatic arthritis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)30830-4
  contributor:
    fullname: Veale
– volume: 33
  year: 2006
  ident: B2
  article-title: Psoriasis, psoriatic arthritis, or psoriatic disease
  publication-title: J Rheumatol
  contributor:
    fullname: Scarpa
– volume: 15
  start-page: R136
  year: 2013
  ident: B36
  article-title: Th17 and Th22 cells in psoriatic arthritis and psoriasis
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar4317
  contributor:
    fullname: Benham
– volume: 60
  year: 2021
  ident: B38
  article-title: Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keaa405
  contributor:
    fullname: Leijten
– volume: 41
  year: 2014
  ident: B45
  article-title: Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils
  publication-title: J Dermatol
  doi: 10.1111/1346-8138.12560
  contributor:
    fullname: Yamanaka
– volume: 36
  start-page: 20
  year: 2017
  ident: B29
  article-title: Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions
  publication-title: Int Rev Immunol
  doi: 10.1080/08830185.2016.1269175
  contributor:
    fullname: Ganesan
– volume: 195
  start-page: 26
  year: 2012
  ident: B32
  article-title: Methods of cell purification: A critical juncture for laboratory research and translational science
  publication-title: Cells Tissues Organs
  doi: 10.1159/000331390
  contributor:
    fullname: Amos
– volume: 21
  year: 2008
  ident: B64
  article-title: Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/039463200802100318
  contributor:
    fullname: Cordiali-Fei
– volume: 39
  year: 2014
  ident: B17
  article-title: Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis
  publication-title: Clin Exp Dermatol
  doi: 10.1111/ced.12251
  contributor:
    fullname: Bosè
– volume: 29
  year: 2008
  ident: B61
  article-title: How interferon-γ keeps autoimmune diseases in check
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2008.07.002
  contributor:
    fullname: Kelchtermans
– volume: 58
  year: 2019
  ident: B56
  article-title: Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/key069
  contributor:
    fullname: Miyagawa
– volume: 46
  year: 2007
  ident: B10
  article-title: Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kel306
  contributor:
    fullname: Szodoray
– volume: 13
  year: 2010
  ident: B25
  article-title: Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32833cf3bc
  contributor:
    fullname: Zhou
– volume: 64
  year: 2005
  ident: B19
  article-title: Psoriasis assessment tools in clinical trials
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.031237
  contributor:
    fullname: Feldman
– volume: 2020
  start-page: 1
  year: 2020
  ident: B60
  article-title: IL-17A in the psoriatic patients’ serum and plaque scales as potential marker of the diseases severity and obesity
  publication-title: Mediators Inflammation
  doi: 10.1155/2020/7420823
  contributor:
    fullname: Michalak-Stoma
– volume: 54
  year: 2006
  ident: B18
  article-title: Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21972
  contributor:
    fullname: Taylor
– volume: 139
  year: 2019
  ident: B50
  article-title: A critical role of the IL-1β-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2018.07.025
  contributor:
    fullname: Cai
– volume: 75
  year: 1990
  ident: B46
  article-title: Interleukin-1 induces interleukin-6 production in peripheral blood monocytes
  publication-title: Blood
  doi: 10.1182/blood.V75.6.1305.1305
  contributor:
    fullname: Tosato
– volume: 19
  year: 2018
  ident: B7
  article-title: Association of proinflammatory cytokine IL-20 gene polymorphism with psoriasis in north Indian population
  publication-title: Egyptian J Med Hum Genet
  doi: 10.1016/j.ejmhg.2017.09.002
  contributor:
    fullname: Wani
– volume: 7
  start-page: 66
  year: 2016
  ident: B39
  article-title: Impact of obesity and metabolic syndrome on immunity
  publication-title: Adv Nutr
  doi: 10.3945/an.115.010207
  contributor:
    fullname: Andersen
– volume: 33
  year: 2014
  ident: B66
  article-title: Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-014-2807-8
  contributor:
    fullname: Cuchacovich
– volume: 55
  year: 2018
  ident: B48
  article-title: The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-018-8702-3
  contributor:
    fullname: Blauvelt
– volume: 153
  year: 2005
  ident: B65
  article-title: Cytokine profiles during infliximab monotherapy in psoriatic arthritis: Cytokine profiles and infliximab monotherapy in PsA
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2005.06648.x
  contributor:
    fullname: Mastroianni
– volume: 19
  year: 2018
  ident: B30
  article-title: Differential inflammatory-response kinetics of human keratinocytes upon cytosolic RNA- and DNA-fragment induction
  publication-title: IJMS
  doi: 10.3390/ijms19030774
  contributor:
    fullname: Danis
– volume: 12
  year: 2021
  ident: B35
  article-title: Single cell analysis of blood mononuclear cells stimulated through either LPS or anti-CD3 and anti-CD28
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.636720
  contributor:
    fullname: Lawlor
– volume: 46
  year: 2019
  ident: B4
  article-title: Psoriatic arthritis, psoriatic disease, or psoriatic syndrome
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.190054
  contributor:
    fullname: Lubrano
– volume: 19
  start-page: 63
  year: 2017
  ident: B5
  article-title: Cardiometabolic disorders in psoriatic disease
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-017-0692-2
  contributor:
    fullname: Sobchak
– volume: 64
  year: 2005
  ident: B27
  article-title: Psoriatic arthritis: Epidemiology, clinical features, course, and outcome
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.032482
  contributor:
    fullname: Gladman
– volume: 97
  start-page: 27
  year: 1991
  ident: B43
  article-title: Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12477880
  contributor:
    fullname: Neuner
– volume: 20
  year: 2019
  ident: B8
  article-title: Polymorphisms in IL36G gene are associated with plaque psoriasis
  publication-title: BMC Med Genet
  doi: 10.1186/s12881-018-0742-2
  contributor:
    fullname: Traks
– volume: 179
  year: 2007
  ident: B34
  article-title: Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.1.41
  contributor:
    fullname: Zanin-Zhorov
– volume: 163
  year: 2010
  ident: B14
  article-title: Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet a and narrowband ultraviolet b therapy: Psoriasis vulgaris cytokines and PUVA/NB-UVB therapy
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2010.09992.x
  contributor:
    fullname: Coimbra
– volume: 23
  year: 2010
  ident: B9
  article-title: Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association
  publication-title: Dermatol Ther
  doi: 10.1111/j.1529-8019.2010.01303.x
  contributor:
    fullname: Duffin
– volume: 4
  year: 2020
  ident: B1
  article-title: Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: Results from a claims database analysis
  publication-title: Rheumatol Adv Pract
  doi: 10.1093/rap/rkaa033
  contributor:
    fullname: Rech
– volume: 59
  year: 2020
  ident: B54
  article-title: Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kez457
  contributor:
    fullname: Feld
– volume: 25
  year: 2020
  ident: B24
  article-title: Downregulation of inflammatory cytokine release from IL-1β and LPS-stimulated PBMC orchestrated by ST2825, a MyD88 dimerisation inhibitor
  publication-title: Molecules
  doi: 10.3390/molecules25184322
  contributor:
    fullname: Ramírez-Pérez
– volume: 34
  year: 2020
  ident: B11
  article-title: A potential inflammatory role of IL-31 in psoriatic arthritis: A correlation with Th17 cytokine profile
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/2058738420907186
  contributor:
    fullname: Bautista-Herrera
SSID ssj0000493335
Score 2.3831208
Snippet ObjectivesPsoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms...
Objectives Psoriatic arthritis (PsA) and cutaneous psoriasis (PsO) are different phenotypes of psoriatic disease (PsD), whose underlying specific mechanisms...
SourceID doaj
pubmedcentral
hal
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 993363
SubjectTerms Biochemistry
Biochemistry, Molecular Biology
Cell Behavior
Cellular Biology
cytokine signature
Dermatology
ex vivo stimulation
Human health and pathology
Immunology
Life Sciences
Molecular biology
psoriasis
psoriatic arthritis (PsA)
psoriatic disease
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuCAqIUFoZxAkpdG0nTtxbqVqtEHBqpd4sxx_aAE1Wze6K_gL-NjN2WiUnLlxycGIrmRln3pPHz4R8qEMQRgmTy8I5ICiszI0zPgcoKwLz0jmJG4W_fZfLq-LLdXk9OeoLa8KSPHAy3LE1ATUMTd1Asg8C-IG0PlQyqKphbuHi33fBJ2TqR8K9QogyLWMCC1PHob252QIf5PwTpGQhxSwRRb1-SC8rrIacQM15oeQk81w8I09HyEhP06s-J498t08ep0Mk716QP-e_6a7d9dTebfqfABrpOqm4gsVp29H10N-i_S0dF2NO6GWslR0obrPEUiGKVRxR4XPAHnYLiNH322HsO7QDNZ2jKIocVQh-TQYFC66iMNJLcnVxfnm2zMfjFXJbVHKTe8BShbEuMO45XEtRLiygJ-m8AlZW-9IE7oNkDs8h5wKoX-GaAmZ5qBS3TLwie13f-deEVkCxBS99WTFfNMqopg5AlGrViGAA0WTk472t9TqpaGhgH-gYHR2j0TE6OSYjn9EbDw-iAHZsgLDQY1jof4VFRt6DL2djLE-_amxDScGilmzHMvLu3tUaZhUulSTzauDq8LcCulZlpJrFwGzI-Z2uXUV9bgUAQHH-5n98xwF5gqaJux_rt2Rvc7v1hwCDNs1RjPi_5CkK3g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1da9RAFB1qRfBF_MRYlVF8ElI7H5kkgkiVlkWsT13o2zCZDzfaJtvN7tL9Bf5t751kZQN98WVhs5uBzLmTew5z51xC3hUhCFMKkyrpHAgUlqXGGZ8ClRWBeeWcwoPCZz_UZCq_XWQXe2Tb3mqYwO5WaYf9pKaLy8Ob681nWPCfUHFCvv0Q6qurFUg9zg8h2wol7pC7HBIjVnidDWz_V0-GhYgtN5lSMoVQlv0-5-2jjDJVNPSH_DPDcskdLjqupNxJTacPyYOBU9LjPggekT3fPCb3-i6Tmyfkz8kNXdfrltrNsv0NrJLOe5tXgITWDZ137QIBsnTYrflIz2MxbUfxHCbWElEs84gWoB3eYVdAKX276oZ7u7qjpnEUXZOjTcHlzqAQm7PonPSUTE9Pzr9O0qH_QmplrpapB7IljXWBcc_hMxPZkQV6pZwvQbYVPjOB-6CYw0blXIA2lK6S8BoIecktE8_IftM2_jmhOWhwwTOf5czLqjRlVQRQUkVZiWCA8iTk_Xau9by32dAgTxAYHYHRCIzugUnIF0Tj3x_RITteaBc_9bDgtDUBvS9NUQFJDAJ0pbI-5CqUecXckUvIW8ByNMbk-LvGa-g5KAvF1iwhb7ZQa1h2uJfST68GMQ-vM9BzeULyUQyMhhz_0tSzaOBdAkMoOX_xPw99QO7jt3gMsnhJ9peLlX8FfGhZvY5R_hc1Pgvr
  priority: 102
  providerName: Scholars Portal
Title Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis
URI https://search.proquest.com/docview/2740512177
https://univ-poitiers.hal.science/hal-03894861
https://pubmed.ncbi.nlm.nih.gov/PMC9678922
https://doaj.org/article/caf1766a8b154f32896cef76f97b1d0d
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoNBL6ZO6j6CUngrejSRLtnpLQpKldEsPCexNyHp0nWbtZb27NL-gfzsj2VvW1150kC1hZsae77NGnxD6XHjPtGQ6FZm1QFAIT7XVLgUoyzxxwloRNgpPf4jJbfZtxmcHiO_2wsSifVNWo_p-MaqreaytXC7MeFcnNv45vZDwhZWUjg_RIaTfPYp-10FexhjvVjCBgMmxrxaLDVBBSkeQjZlggxwUpfohs8xDIeQeyhzWSO4lnavn6FmPFvFZ91Qv0IGrX6In3fmRD6_Q38s_eFttG2we1s1vwIt42Qm4grFxVeNl26yC6Q3u12G-4ptYJtvisMMyVAnhUMARxT3bMMJsACy6ZtP2Y9uqxbq2OOghRwGC-71JwVjzqIn0Gt1eXd5cTNL-ZIXUZLlYpw5gVKaN9YQ6Ci1n_NQAcBLWSSBkhePaU-cFseEIcsqA9WW2zOAF97mkhrA36KhuavcW4RzYNaPc8Zy4rJRaloUHjlTIknkNYCZBX3a2VstOQEMB8QiOUdExKjhGdY5J0Hnwxr8bg_Z17GhWv1QfAcpoH1QtdVEC_PMMGKMwzufCy7wk9tQm6BP4cjDH5Oy7Cn1BTTArBNmSBJ3sXK3ghQqrJJ15FdB0-FABU8sTlA9iYDDl8ApEapTm7iPz3X-PfI-eBnvE3Y7FB3S0Xm3cR4A96_I4_i6A9npGoJ1mxXEM_Edi1Qvq
link.rule.ids 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGEIIXxFV042IQT0hpZzt2Yt7GtKlAO_HQSXuzHF_WwJpUTVuxX8Df5thJUfPKSx6c2IrOOba_Tz7nM0Ifc--ZlkwnIrUWCArhibbaJQBlmSdOWCtCofD0Uoyv0m_X_PoA8V0tTEzaN0U5rG4Xw6qcx9zK5cKMdnliox_TMwkrrKR0dA_d5yyTZI-k_2xBL2OMt2eYQMHkyJeLxQbIIKVD2I-ZYL1dKIr1w94yD6mQeziznyW5t-1cPEGPO7yIT9v_eooOXPUMPWhvkLx7jv6c_8bbcltjc7eufwFixMtWwhXMjcsKL5t6FYxvcHcS8xnPYqJsg0ONZcgTwiGFI8p7NqGH2QBcdPWm6fo2ZYN1ZXFQRI4SBLd7g4K55lEV6QW6ujifnY2T7m6FxKSZWCcOgFSqjfWEOgpPzviJAegkrJNAyXLHtafOC2LDJeSUAe9LbZHCFPeZpIawl-iwqiv3CuEM-DWj3PGMuLSQWha5B5aUy4J5DXBmgD7tbK2WrYSGAuoRHKOiY1RwjGodM0Bfgjf-fRjUr2NDvbpRXQwoo33QtdR5AQDQM-CMwjifCS-zgtgTO0AfwJe9McanExXagp5gmguyJQP0fudqBVMqnJO05lVA1GGpAq6WDVDWi4HekP03EKtRnLuLzaP_7vkOPRzPphM1-Xr5_Rg9CraJtY_5a3S4Xm3cGwBB6-JtDPm_tLIMfw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWgCNQLKl8ipQWDOCFl09iJE3MrpasF2qqHVurNcvzBBrpJtNldtb-Av83YyaLkyiUHJ7aimbH9njx-g9DH3FoqOZUhS7QGghKnodTShABlqY0N05q5i8LnF2x2nXy_SW8Gpb580r4qykl1u5hU5dznVjYLFW3zxKLL8xMOKywnJGq0jR6iRymFIBsQ9V8d8KWUpt05JtAwHtlysVgDISRkAnsyZXS0E3nBfthf5i4dcoA1x5mSg61nuoee9pgRH3f_9gw9MNVz9LirInn_Av05vcObclNjdb-qfwNqxE0n4womx2WFm7ZeOgco3J_GfMZXPlm2xe6epcsVwi6Nw0t8tq6HWgNkNPW67fu2ZYtlpbFTRfYyBLeDQcFkc6-M9BJdT0-vTmZhX18hVEnGVqEBMJVIpW1MDIFnStMjBfCJacOBluUmlZYYy2LtCpETCtwv0UUC09xmnKiYvkI7VV2Z1whnwLEpSU2axSYpuORFboEp5bygVgKkCdCnra1F08loCKAfzjHCO0Y4x4jOMQH64rzx70OngO0b6uVP0ceBUNI6bUuZFwACLQXeyJSxGbM8K2J9pAP0AXw5GmN2fCZcm9MUTHIWb-IAvd-6WsC0cmclnXkFkHVYroCvZQHKRjEwGnL8BuLVC3T38bn_3z3foSeXX6fi7NvFjzdo15nGX3_MD9DOark2h4CDVsVbH_F_AXHTDZI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ex+vivo+cytokine+production+in+psoriatic+disease%3A+Towards+specific+signatures+in+cutaneous+psoriasis+and+peripheral+psoriatic+arthritis&rft.jtitle=Frontiers+in+immunology&rft.au=Larid%2C+Guillaume&rft.au=Delwail%2C+Adriana&rft.au=Dalle%2C+Thomas&rft.au=Vasseur%2C+Philippe&rft.date=2022-11-08&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=13&rft_id=info:doi/10.3389%2Ffimmu.2022.993363&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2022_993363
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon